Seminar Briefings / Office of Health Economics
Citation Profile [Updated: 2023-01-07 21:26:51]
5 Years H Index
3
Impact Factor (IF)
0
5 Years IF
0
Data available in this
report
[Raw
data] [50 most cited papers]
[50 most relevant papers]
[cites used to compute IF]
[Recent
citations ][Frequent citing
series ] [more data in
EconPapers]
[
trace new citations] [Missing
citations? Add them now]
[Incorrect content? Let us
know]
Main indicators
Raw Data
| IF | AIF | CIF | IF5 | DOC | CDO | CIT | NCI | CCU | D2Y | C2Y | D5Y | C5Y | SC | %SC | CiY | II | AII | |
| 1999 | 0 | 0.38 | 0 | 0 | 3 | 3 | 1 | 0 | 0 | 0 | 0 | 0 | 0.25 | |||||
| 2002 | 0 | 0.52 | 0 | 0 | 1 | 4 | 0 | 0 | 0 | 3 | 0 | 0 | 0.29 | |||||
| 2003 | 0 | 0.51 | 0 | 0 | 1 | 5 | 0 | 0 | 1 | 4 | 0 | 0 | 0.29 | |||||
| 2010 | 0 | 0.51 | 0 | 0 | 2 | 7 | 3 | 1 | 0 | 0 | 0 | 0 | 0.29 | |||||
| 2011 | 0.5 | 0.6 | 0.1 | 0.5 | 3 | 10 | 3 | 1 | 2 | 2 | 1 | 2 | 1 | 0 | 0 | 0.35 | ||
| 2012 | 0.2 | 0.65 | 0.08 | 0.2 | 2 | 12 | 0 | 1 | 3 | 5 | 1 | 5 | 1 | 1 | 100 | 0 | 0.34 | |
| 2014 | 0 | 0.65 | 0.2 | 0.29 | 3 | 15 | 2 | 3 | 7 | 2 | 7 | 2 | 0 | 1 | 0.33 | 0.34 | ||
| 2015 | 0 | 0.63 | 0.11 | 0 | 3 | 18 | 10 | 9 | 3 | 10 | 0 | 0 | 0.35 | |||||
| 2016 | 0.33 | 0.63 | 0.11 | 0.18 | 1 | 19 | 1 | 2 | 11 | 6 | 2 | 11 | 2 | 0 | 0 | 0.34 | ||
| 2017 | 0.5 | 0.62 | 0.24 | 0.22 | 2 | 21 | 1 | 5 | 16 | 4 | 2 | 9 | 2 | 0 | 0 | 0.34 | ||
| 2018 | 0.33 | 0.62 | 0.25 | 0.56 | 3 | 24 | 0 | 6 | 22 | 3 | 1 | 9 | 5 | 0 | 0 | 0.35 | ||
| 2019 | 0 | 0.62 | 0.04 | 0 | 1 | 25 | 0 | 1 | 23 | 5 | 12 | 0 | 0 | 0.37 | ||||
| 2020 | 0.25 | 0.7 | 0.13 | 0.3 | 6 | 31 | 0 | 4 | 27 | 4 | 1 | 10 | 3 | 0 | 0 | 0.72 |
| IF: | Two years Impact Factor: C2Y / D2Y |
| AIF: | Average Impact Factor for all series in RePEc in year y |
| CIF: | Cumulative impact factor |
| IF5: | Five years Impact Factor: C5Y / D5Y |
| DOC: | Number of documents published in year y |
| CDO: | Cumulative number of documents published until year y |
| CIT: | Number of citations to papers published in year y |
| NCI: | Number of citations in year y |
| CCU: | Cumulative number of citations to papers published until year y |
| D2Y: | Number of articles published in y-1 plus y-2 |
| C2Y: | Cites in y to articles published in y-1 plus y-2 |
| D5Y: | Number of articles published in y-1 until y-5 |
| C5Y: | Cites in y to articles published in y-1 until y-5 |
| SC: | selft citations in y to articles published in y-1 plus y-2 |
| %SC: | Percentage of selft citations in y to articles published in y-1 plus y-2 |
| CiY: | Cites in year y to documents published in year y |
| II: | Immediacy Index: CiY / Documents. |
| AII: | Average Immediacy Index for series in RePEc in year y |
50 most cited documents in this series
| # | Year | Title | Cited |
|---|---|---|---|
| 1 | 2015 | Multi-indication Pricing: Pros, Cons and Applicability to the UK. (2015). Towse, Adrian ; Pistollato, M ; Dellamano, R ; Mestre-Ferrandiz, J. In: Seminar Briefings. RePEc:ohe:sembri:001653. Full description at Econpapers || Download paper | 8 |
| 2 | 2011 | Willingness to Pay and Publicly Funded Health Care: Contradiction in Terms?. (2011). Donaldson, C. In: Seminar Briefings. RePEc:ohe:sembri:000173. Full description at Econpapers || Download paper | 4 |
| 3 | 2015 | A Framework for Payer Assessment of the Value of New Technologies: A US Approach. (2015). Pearson, S. In: Seminar Briefings. RePEc:ohe:sembri:001589. Full description at Econpapers || Download paper | 3 |
| 4 | 2016 | Waiting Time Policies in the Health Sector. (2016). Siciliani, Luigi. In: Seminar Briefings. RePEc:ohe:sembri:001724. Full description at Econpapers || Download paper | 2 |
| 5 | 1999 | Public Involvement in Priority Setting. (1999). Ed, L. In: Seminar Briefings. RePEc:ohe:sembri:000451. Full description at Econpapers || Download paper | 2 |
| 6 | 2010 | Innovation in Medicines: Can We Value Progress?. (2010). Sussex, J. In: Seminar Briefings. RePEc:ohe:sembri:000219. Full description at Econpapers || Download paper | 2 |
| 7 | 2010 | Science Policy Research: Having an Impact on Policy?. (2010). Martin, Ben. In: Seminar Briefings. RePEc:ohe:sembri:000197. Full description at Econpapers || Download paper | 2 |
| 8 | 2014 | Biosimilar Competition: Lessons from Europe and Prospects for the US. (2014). Grabowski, H. In: Seminar Briefings. RePEc:ohe:sembri:001556. Full description at Econpapers || Download paper | 2 |
| 9 | 2017 | Delivering an Outcomes-based NHS: Creating the Right Conditions. (2017). Hicks, N. In: Seminar Briefings. RePEc:ohe:sembri:001804. Full description at Econpapers || Download paper | 2 |
| 10 | 2012 | Value Based Pricing in Sweden: Lessons for Design?. (2012). Persson, U. In: Seminar Briefings. RePEc:ohe:sembri:000141. Full description at Econpapers || Download paper | 1 |
| 11 | 2014 | Can the US Afford to Ignore Cost-effectiveness Evidence?. (2014). Chambers, J. In: Seminar Briefings. RePEc:ohe:sembri:000074. Full description at Econpapers || Download paper | 1 |
| 12 | 2019 | Early Experience with Health Technology Assessment of Gene Therapies in the United States: Pricing and Paying for Cures. (2019). Pearson, S. In: Seminar Briefings. RePEc:ohe:sembri:002112. Full description at Econpapers || Download paper | 1 |
| 13 | 2003 | Mental Health Economics and Policy in a Global Context. (2003). Sussex, J. In: Seminar Briefings. RePEc:ohe:sembri:000482. Full description at Econpapers || Download paper | 1 |
50 most relevant documents in this series (papers most cited in the last two years)
| # | Year | Title | Cited |
|---|---|---|---|
| 1 | 2015 | Multi-indication Pricing: Pros, Cons and Applicability to the UK. (2015). Towse, Adrian ; Pistollato, M ; Dellamano, R ; Mestre-Ferrandiz, J. In: Seminar Briefings. RePEc:ohe:sembri:001653. Full description at Econpapers || Download paper | 4 |
Citing documents used to
compute impact factor:
| Year | Title |
|---|
Recent citations
10 most frequent citing series